Free Trial

TradeUP Acquisition (UPTDW) Competitors

$0.13 0.00 (0.00%)
As of 05/29/2026

UPTDW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy TradeUP Acquisition stock or one of its competitors? MarketBeat compares TradeUP Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TradeUP Acquisition include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does TradeUP Acquisition compare to Ainos?

TradeUP Acquisition (NASDAQ:UPTDW) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TradeUP AcquisitionN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Ainos had 2 more articles in the media than TradeUP Acquisition. MarketBeat recorded 2 mentions for Ainos and 0 mentions for TradeUP Acquisition. Ainos' average media sentiment score of 0.44 beat TradeUP Acquisition's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
TradeUP Acquisition Neutral
Ainos Neutral

Company Net Margins Return on Equity Return on Assets
TradeUP AcquisitionN/A N/A N/A
Ainos N/A N/A N/A

Summary

Ainos beats TradeUP Acquisition on 3 of the 3 factors compared between the two stocks.

How does TradeUP Acquisition compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and TradeUP Acquisition (NASDAQ:UPTDW) are both pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
TradeUP Acquisition N/A N/A N/A

In the previous week, Alvotech had 2 more articles in the media than TradeUP Acquisition. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for TradeUP Acquisition. Alvotech's average media sentiment score of 1.44 beat TradeUP Acquisition's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
TradeUP Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
TradeUP AcquisitionN/AN/AN/AN/AN/A

Summary

Alvotech beats TradeUP Acquisition on 3 of the 3 factors compared between the two stocks.

How does TradeUP Acquisition compare to Aravive?

TradeUP Acquisition (NASDAQ:UPTDW) and Aravive (NASDAQ:ARAV) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TradeUP AcquisitionN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
TradeUP AcquisitionN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, TradeUP Acquisition's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
TradeUP Acquisition Neutral
Aravive Neutral

Summary

Aravive beats TradeUP Acquisition on 2 of the 2 factors compared between the two stocks.

How does TradeUP Acquisition compare to Atlantic Coastal Acquisition Corp. II?

TradeUP Acquisition (NASDAQ:UPTDW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

In the previous week, TradeUP Acquisition's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
TradeUP Acquisition Neutral
Atlantic Coastal Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TradeUP AcquisitionN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
TradeUP AcquisitionN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

TradeUP Acquisition and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does TradeUP Acquisition compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and TradeUP Acquisition (NASDAQ:UPTDW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

In the previous week, Biofrontera had 2 more articles in the media than TradeUP Acquisition. MarketBeat recorded 2 mentions for Biofrontera and 0 mentions for TradeUP Acquisition. Biofrontera's average media sentiment score of 0.43 beat TradeUP Acquisition's score of 0.00 indicating that Biofrontera is being referred to more favorably in the media.

Company Overall Sentiment
Biofrontera Neutral
TradeUP Acquisition Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
TradeUP Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
TradeUP AcquisitionN/AN/AN/AN/AN/A

Summary

Biofrontera beats TradeUP Acquisition on 3 of the 3 factors compared between the two stocks.

Get TradeUP Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPTDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPTDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPTDW vs. The Competition

MetricTradeUP AcquisitionBiological Products, Except Diagnostic Substances IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$463.50M$4.38B$12.61B
Dividend YieldN/AN/A6.19%5.24%
P/E RatioN/AN/A21.8026.29
Price / SalesN/A71.99238.2393.62
Price / CashN/AN/A58.1457.38
Price / BookN/A3.5732.817.32
Net IncomeN/A-$81.71M$111.12M$337.27M
7 Day PerformanceN/A2.58%2.83%3.58%
1 Month Performance11.30%1.77%6.58%5.71%
1 Year PerformanceN/AN/A17.41%39.75%

TradeUP Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPTDW
TradeUP Acquisition
N/A$0.13
flat
N/A+110.5%$0.00N/AN/A3
AIMDW
Ainos
N/A$0.05
-26.7%
N/A-16.1%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.22
+10.0%
N/A-87.3%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:UPTDW) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners